Long‐term continuation with secukinumab in psoriasis: association with patient profile and initial psoriasis clearance

L Ferrières, MP Konstantinou… - Clinical and …, 2019 - academic.oup.com
Background There are limited data regarding the long‐term continuation with biological
therapy for patients with psoriasis. In particular, the reasons for secukinumab discontinuation …
被引用次数：18 相关文章

Long-term continuation with secukinumab in psoriasis: association with patient profile and initial psoriasis clearance.

L Ferrières, MP Konstantinou, S Hegazy… - Clinical and …, 2019 - europepmc.org
Background There are limited data regarding the long-term continuation with biological
therapy for patients with psoriasis. In particular, the reasons for secukinumab discontinuation …

Long‐term continuation with secukinumab in psoriasis: association with patient profile and initial psoriasis clearance.

L Ferrières, MP Konstantinou… - Clinical & …, 2019 - search.ebscohost.com
Background: There are limited data regarding the long‐term continuation with biological
therapy for patients with psoriasis. In particular, the reasons for secukinumab discontinuation …

Long‐term continuation with secukinumab in psoriasis: association with patient profile and initial psoriasis clearance

L Ferrières, MP Konstantinou… - Clinical and …, 2019 - Wiley Online Library
Background There are limited data regarding the long‐term continuation with biological
therapy for patients with psoriasis. In particular, the reasons for secukinumab discontinuation …

Long-term continuation with secukinumab in psoriasis: association with patient profile and initial psoriasis clearance

L Ferrières, MP Konstantinou… - Clinical and …, 2019 - pubmed.ncbi.nlm.nih.gov
Background There are limited data regarding the long-term continuation with biological
therapy for patients with psoriasis. In particular, the reasons for secukinumab discontinuation …